OptiNose, Inc. Business Finance Contracts & Agreements

31 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Securities Purchase Agreement
Purchase Agreements
OptiNose, Inc.
2024
Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
OptiNose, Inc.
2024
First Amendment and Waiver to the Note Purchase Agreement
Note Agreements
OptiNose, Inc.
2024
Warrant Agency Agreement, dated November 23, 2022, by and between OptiNose, Inc. and Broadridge Corporate Issuer Solutions, Inc
Warrant Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Form of Warrant
Warrant Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Underwriting Agreement, dated November 21, 2022, by and between OptiNose, Inc. and Piper Sandler & Co
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Fourth Amendment, dated November 9, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose Inc., OptiNose UK Limited and OptiNose AS,...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Third Amendment, dated August 10, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS,...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2022
Third Amendment, dated August 10, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS,...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2022
Underwriting Agreement, dated November 16, 2021, by and between OptiNose, Inc. and Piper Sandler & Co
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2021
Second Amendment to the Note Purchase Agreement, dated November 16, 2021, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2021
Form of New Warrant
Warrant Agreements
OptiNose, Inc.
Pharmaceuticals
2021
First Amendment to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2021
Amendment Letter to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2020
Underwriting Agreement, dated August 13, 2020, by and between Opti
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2020
Form of Restricted Stock Unit Agreement (Inducement Grant)
Stock Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2020
Note dated April 6, 2020, between OptiNose US, Inc. and JPMorgan Chase Bank, N.A
Note Agreements
OptiNose, Inc.
Pharmaceuticals
OH
2020
Underwriting Agreement, dated November 20, 2019, by and between OptiNose, Inc., Jefferies LLC, Cowen and Company, LLC, Piper Jaffray & Co. and the Selling Stockholders named...
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2019
Common Stock Warrant issued by Optinose, Inc. dated September 12, 2019
Warrant Agreements
OptiNose, Inc.
Pharmaceuticals
2019
Form of Underwriting Agreement
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2018
2017 Employee Stock Purchase Plan
Stock Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
First Amendment to the Second Amended and Restated Registration Rights Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Registration Rights Agreements
OptiNose, Inc.
Pharmaceuticals
2017
First Amendment to the Second Amended and Restated Shareholders Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Shareholders Agreements
OptiNose, Inc.
Pharmaceuticals
2017
Form of Underwriting Agreement
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2017
2017 Employee Stock Purchase Plan
Stock Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
First Amendment to the Second Amended and Restated Registration Rights Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Registration Rights Agreements
OptiNose, Inc.
Pharmaceuticals
2017
First Amendment to the Second Amended and Restated Shareholders Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Shareholders Agreements
OptiNose, Inc.
Pharmaceuticals
2017
Form of Warrant issued by the Registrant on June 7, 2010
Warrant Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Second Amended and Restated Shareholders' Agreement, dated March 24, 2017, by and among the Registrant and certain of its stockholders
Shareholders Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2017
Second Amended and Restated Registration Rights Agreement, dated March 24, 2017, by and among the Registrant and certain of its stockholders
Registration Rights Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Exchange Agreement, dated as of June 7, 2010, by and among the Registrant, OptiNose AS and the other signatories thereto (the Registrant hereby agrees to furnish supplementally a...
Exchange Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017